140 related articles for article (PubMed ID: 28926893)
1. [Effect of intratumor heterogeneity of esophageal squamous cell carcinoma on chemotherapy sensitivity].
Sun L; Wu W; Yan M; Han PL; Zhan X; Ma XW; Cao XG; Zhao S; Gao F; Qi Y; Cao W
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):657-663. PubMed ID: 28926893
[No Abstract] [Full Text] [Related]
2. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
Chen C; Ma Z; Zhang H; Liu X; Yu Z
Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
[TBL] [Abstract][Full Text] [Related]
3. MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.
Li Z; Li S; Wen Y; Chen J; Liu K; Jia J
Technol Cancer Res Treat; 2021; 20():15330338211039127. PubMed ID: 34747666
[No Abstract] [Full Text] [Related]
4. Nimotuzumab with cisplatin or fluorouracil on human esophageal squamous cell carcinoma EC1 cells.
Ji YH; Yang XY; Wu JQ; Huo XQ; Li WW; Li GJ; Mu YL; Lu P
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):586-91. PubMed ID: 25753875
[TBL] [Abstract][Full Text] [Related]
5. RIPK1 contributes to cisplatin-induced apoptosis of esophageal squamous cell carcinoma cells via activation of JNK pathway.
Zhang Y; Du J; Duan X; Peng W; Lv L; Chen Z; Zhang Y
Life Sci; 2021 Mar; 269():119064. PubMed ID: 33460665
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of KCNMA1 facilitates the reversal effect of verapamil on the chemoresistance to cisplatin of esophageal squamous cell carcinoma cells.
Ge N; Yang GS; Zhang TY; Chang N; Kang YH; Zhou Q; Fan PS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1869-1880. PubMed ID: 33660797
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
Liu X; Yan Y; Ma W; Wu S
Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
[TBL] [Abstract][Full Text] [Related]
8. Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells.
Gao D; Hu J; Zhang X; Gao C; Hong J
Cancer Biother Radiopharm; 2013; 28(6):433-40. PubMed ID: 23806019
[TBL] [Abstract][Full Text] [Related]
9. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
[TBL] [Abstract][Full Text] [Related]
10. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
12. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Qiu F; Liu L; Lin Y; Yang Z; Qiu F
Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
[TBL] [Abstract][Full Text] [Related]
13. ATG7 deficiency promote apoptotic death induced by Cisplatin in human esophageal squamous cell carcinoma cells.
Zhu L; Du H; Shi M; Chen Z; Hang J
Bull Cancer; 2013; 100(7-8):15-21. PubMed ID: 23823853
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma.
Mi YJ; Gao J; Xie JD; Cao JY; Cui SX; Gao HJ; Yao SP; Liu T; Zhang YY; Guo CH; Qiu GQ; Chen YQ
Dis Esophagus; 2013 Aug; 26(6):636-43. PubMed ID: 23163484
[TBL] [Abstract][Full Text] [Related]
15. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
[TBL] [Abstract][Full Text] [Related]
16. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
17. HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2.
Li J; Sang M; Zheng Y; Meng L; Gu L; Li Z; Liu F; Wu Y; Li W; Shan B
Exp Cell Res; 2021 Dec; 409(1):112891. PubMed ID: 34688610
[TBL] [Abstract][Full Text] [Related]
18. P21-activated kinase 7 mediates cisplatin-resistance of esophageal squamous carcinoma cells with Aurora-A overexpression.
He S; Feng M; Liu M; Yang S; Yan S; Zhang W; Wang Z; Hu C; Xu Q; Chen L; Zhu H; Xu N
PLoS One; 2014; 9(12):e113989. PubMed ID: 25436453
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
20.
Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
